10820 Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 

ACTION: Notice of application. 

SUMMARY: S&B Pharma LLC has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 26, 2022. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 24, 2021, 

S&B Pharma LLC, 405 South Motor 

Avenue, Azusa, California 91702, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric 

Acid.

2010 I 

Marihuana ..................... 7360 I 

Tetrahydrocannabinols 7370 I 

Amphetamine ............... 1100 II 

Methamphetamine ........ 1105 II 

Lisdexamfetamine ........ 1205 II 

Methylphenidate ........... 1724 II 

Pentobarbital ................ 2270 II 

4-Anilino-N-Phenethyl4-Piperidine (ANPP).8333 II 

Tapentadol .................... 9780 II 

Fentanyl ........................ 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates for formulation and 

analytical development purposes or for 

sale to its customers. In reference to dug 

codes 7360 (Marihuana), and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as synthetic. No other activities for these 

drug codes are authorized for this 

registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–04062 Filed 2–24–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–974] 

Bulk Manufacturer of Controlled 

Substances Application: Cedarburg 

Pharmaceuticals 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cedarburg Pharmaceuticals 

has applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplemental Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 26, 2022. 

ADDRESSES: DEA requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to http:// 

www.regulations.gov and follow the 

online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on http://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment.’’ 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on August 27, 2021, 

Cedarburg Pharmaceuticals, 870 Badger 

Circle, Grafton, Wisconsin 53024–0000, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Lysergic Acid 

Diethylamide.

7315 I 

Tetrahydrocannabinols 7370 I 

4-Bromo-2,5- 

Dimethoxyphenethylamine.

7392 I 

3,4- 

Methylenediocyamphetamine.

7400 I 

Controlled substance Drug 

code Schedule 

3.4- 

Methylenedioxymethamphetamine.

7405 I 

5-Methoxy-N-Ndimethltryptamine.7431 I 

Dimethyltryptamine ....... 7435 I 

Psilocybin ..................... 7437 I 

Psilocyn ........................ 7438 I 

Methylphenidate ........... 1724 II 

Nabilone ....................... 7379 II 

4-Anilino-N-Phenethyl4-Piperidine (ANPP).8333 II 

Fentanyl ........................ 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances for the internal use 

intermediates or for sale to its 

customers. In reference to the drug code 

7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture as 

synthetic. No other activity for this drug 

code is authorized for this registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–04064 Filed 2–24–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–964] 

Bulk Manufacturer of Controlled 

Substances Application: Synthcon 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Synthcon LLC has applied to 

be registered as a bulk manufacturer of 

basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTAL

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 26, 2022. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on December 2, 2021, 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 10821 

Synthcon LLC, 770 Wooten Road, Suite 

101, Colorado Springs, Colorado 80915– 

3538, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug code Schedule 

3-FMC ................................................................................................................................................................................ 1233 I 

Cathinone .......................................................................................................................................................................... 1235 I 

Methcathinone ................................................................................................................................................................... 1237 I 

4-FMC ................................................................................................................................................................................ 1238 I 

Pentedrone ........................................................................................................................................................................ 1246 I 

Mephedrone(4-Methyl-N-methylcathinone) ....................................................................................................................... 1248 I 

4-MEC ................................................................................................................................................................................ 1249 I 

Naphyrone ......................................................................................................................................................................... 1258 I 

N-Ethylamphetamine ......................................................................................................................................................... 1475 I 

N,N-Dimethylamphetamine ................................................................................................................................................ 1480 I 

Aminorex ............................................................................................................................................................................ 1585 I 

Cis-4-Methylaminorex ........................................................................................................................................................ 1590 I 

GHB ................................................................................................................................................................................... 2010 I 

Methaqualone .................................................................................................................................................................... 2565 I 

Mecloqualone .................................................................................................................................................................... 2572 I 

JWH-250 ............................................................................................................................................................................ 6250 I 

ADB-PINACA ..................................................................................................................................................................... 7035 I 

JWH-018 ............................................................................................................................................................................ 7118 I 

JWH-073 ............................................................................................................................................................................ 7173 I 

JWH-200 ............................................................................................................................................................................ 7200 I 

JWH-203 ............................................................................................................................................................................ 7203 I 

4-Methyl-alpha-ethylaminopentiophenone ......................................................................................................................... 7245 I 

N-Ethyhexedrone ............................................................................................................................................................... 7246 I 

AET .................................................................................................................................................................................... 7249 I 

Ibogaine ............................................................................................................................................................................. 7260 I 

CP-47,497 .......................................................................................................................................................................... 7297 I 

CP-47,497 C8 HOMOLOG ................................................................................................................................................ 7298 I 

LSD .................................................................................................................................................................................... 7315 I 

2C-T-7 ................................................................................................................................................................................ 7348 I 

Tetrahydrocannabinols ...................................................................................................................................................... 7370 I 

Mescaline ........................................................................................................................................................................... 7381 I 

2C-T-2 ................................................................................................................................................................................ 7385 I 

3,4,5-TMA .......................................................................................................................................................................... 7390 I 

DOB ................................................................................................................................................................................... 7391 I 

2CB .................................................................................................................................................................................... 7392 I 

DOM .................................................................................................................................................................................. 7395 I 

2,5-DMA ............................................................................................................................................................................. 7396 I 

JWH-398 ............................................................................................................................................................................ 7398 I 

DOE ................................................................................................................................................................................... 7399 I 

MDA ................................................................................................................................................................................... 7400 I 

5-METHOXY-MDA ............................................................................................................................................................. 7401 I 

N-HYDROXY-MDA ............................................................................................................................................................ 7402 I 

MDEA ................................................................................................................................................................................ 7404 I 

MDMA ................................................................................................................................................................................ 7405 I 

PMA ................................................................................................................................................................................... 7411 I 

5-MeO-DMT ....................................................................................................................................................................... 7431 I 

AMT ................................................................................................................................................................................... 7432 I 

Bufotenine .......................................................................................................................................................................... 7433 I 

DET .................................................................................................................................................................................... 7434 I 

DMT ................................................................................................................................................................................... 7435 I 

Psilocybin ........................................................................................................................................................................... 7437 I 

Psilocin .............................................................................................................................................................................. 7438 I 

5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................... 7439 I 

4-Methyl-alpha-pyrrolidinohexiophenone ........................................................................................................................... 7446 I 

PCE ................................................................................................................................................................................... 7455 I 

PCPy .................................................................................................................................................................................. 7458 I 

TCP .................................................................................................................................................................................... 7470 I 

TCPy .................................................................................................................................................................................. 7473 I 

JB323 ................................................................................................................................................................................. 7482 I 

JB336 ................................................................................................................................................................................. 7484 I 

BZP .................................................................................................................................................................................... 7493 I 

4-MePPP ........................................................................................................................................................................... 7498 I 

2C-D .................................................................................................................................................................................. 7508 I 

2C-E ................................................................................................................................................................................... 7509 I 

2C-H .................................................................................................................................................................................. 7517 I 

2C-I .................................................................................................................................................................................... 7518 I 

2C-C .................................................................................................................................................................................. 7519 I 

2C-N .................................................................................................................................................................................. 7521 I 

2C-P ................................................................................................................................................................................... 7524 I 

2C-T-4 ................................................................................................................................................................................ 7532 I 


lotter on DSK11XQN23PROD with NOTICES1
10822 Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 

Controlled substance Drug code Schedule 

MDPV ................................................................................................................................................................................ 7535 I 

25B-NBOME ...................................................................................................................................................................... 7536 I 

25C-NBOME ...................................................................................................................................................................... 7537 I 

25I-NBOME ....................................................................................................................................................................... 7538 I 

Methylone .......................................................................................................................................................................... 7540 I 

Butylone ............................................................................................................................................................................. 7541 I 

Pentylone ........................................................................................................................................................................... 7542 I 

N-Ethylpentyloe ................................................................................................................................................................. 7543 I 

Alpha-Pyrrolidinohexanophenone ...................................................................................................................................... 7544 I 

Alpha-PVP ......................................................................................................................................................................... 7545 I 

Alpha-PBP ......................................................................................................................................................................... 7546 I 

Ethylone ............................................................................................................................................................................. 7547 I 

AM-694 .............................................................................................................................................................................. 7694 I 

Etorphine ........................................................................................................................................................................... 9056 I 

Heroin ................................................................................................................................................................................ 9200 I 

Normorphine ...................................................................................................................................................................... 9313 I 

Acetorphine ........................................................................................................................................................................ 9319 I 

U-47700 ............................................................................................................................................................................. 9547 I 

AH-7921 ............................................................................................................................................................................. 9551 I 

MT-45 ................................................................................................................................................................................ 9560 I 

Acetylmethadol .................................................................................................................................................................. 9601 I 

Allylprodine ........................................................................................................................................................................ 9602 I 

Alphacetylmethadol ........................................................................................................................................................... 9603 I 

Alphameprodine ................................................................................................................................................................. 9604 I 

Alphamethadol ................................................................................................................................................................... 9605 I 

Benzethidine ...................................................................................................................................................................... 9606 I 

Betacetylmethadol ............................................................................................................................................................. 9607 I 

Clonitazine ......................................................................................................................................................................... 9612 I 

Isontonitazene ................................................................................................................................................................... 9614 I 

Diampromide ..................................................................................................................................................................... 9615 I 

Diethylthiambutene ............................................................................................................................................................ 9616 I 

Dimethylthiambutene ......................................................................................................................................................... 9619 I 

Etonitazene ........................................................................................................................................................................ 9624 I 

Ketobemidone .................................................................................................................................................................... 9628 I 

MPPP ................................................................................................................................................................................. 9661 I 

PEPAP ............................................................................................................................................................................... 9663 I 

Tilidine ............................................................................................................................................................................... 9750 I 

Acryl Fentanyl .................................................................................................................................................................... 9811 I 

Para-fluorofentanyl ............................................................................................................................................................ 9812 I 

3-Methylfentanyl ................................................................................................................................................................ 9813 I 

Alpha-methylfentanyl ......................................................................................................................................................... 9814 I 

Acetyl-alpha-methylfentanyl ............................................................................................................................................... 9815 I 

Ortho-fluorofentanyl ........................................................................................................................................................... 9816 I 

Acetylfentanyl .................................................................................................................................................................... 9821 I 

Butyrylfentanyl ................................................................................................................................................................... 9822 I 

Para-fluorofentanyl ............................................................................................................................................................ 9823 I 

4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ........................................... 9824 I 

Methoxyacetyl fentanyl ...................................................................................................................................................... 9825 I 

Para-chloroisobutyryl fentanyl ........................................................................................................................................... 9826 I 

Isobutyrylfentanyl ............................................................................................................................................................... 9827 I 

Beta-Hydroxyfentanyl ........................................................................................................................................................ 9830 I 

Beta-Hydroxy-3-methylfentanyl ......................................................................................................................................... 9831 I 

Alpha-Methylthiofentanyl ................................................................................................................................................... 9832 I 

3-Methylthiofentanyl ........................................................................................................................................................... 9833 I 

Furanylfentanyl .................................................................................................................................................................. 9834 I 

Thiofentanyl ....................................................................................................................................................................... 9835 I 

Beta-Hydroxythiofentanyl ................................................................................................................................................... 9836 I 

Para-Methoxybutyryl Fetnanyl ........................................................................................................................................... 9837 I 

Ocfentanil ........................................................................................................................................................................... 9838 I 

Valeryl Fentanyl ................................................................................................................................................................. 9840 I 

Tetrahydrofuranyl Fentanyl ................................................................................................................................................ 9843 I 

Crotonyl Fentanyl .............................................................................................................................................................. 9844 I 

Cyclopropyl Fentanyl ......................................................................................................................................................... 9845 I 

Cyclopentyl Fentanyl ......................................................................................................................................................... 9847 I 

Fentanyl Related Compounds ........................................................................................................................................... 9850 I 

Amphetamine ..................................................................................................................................................................... 1100 II 

Methamphetamine ............................................................................................................................................................. 1105 II 

1-Phenylcyclohexylamine .................................................................................................................................................. 7460 II 

PCP ................................................................................................................................................................................... 7471 II 

ANPP ................................................................................................................................................................................. 8333 II 

Norfentanyl ........................................................................................................................................................................ 8366 II 

P2P .................................................................................................................................................................................... 8501 II 

PCC ................................................................................................................................................................................... 8603 II 

Alphaprodine ...................................................................................................................................................................... 9010 II 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 38 / Friday, February 25, 2022 / Notices 10823 

Controlled substance Drug code Schedule 

Anileridine .......................................................................................................................................................................... 9020 II 

Cocaine .............................................................................................................................................................................. 9041 II 

Diphenoxylate .................................................................................................................................................................... 9170 II 

Ecgonine ............................................................................................................................................................................ 9180 II 

Levorphanol ....................................................................................................................................................................... 9220 II 

Meperidine ......................................................................................................................................................................... 9230 II 

Meperidine Intermediate-A ................................................................................................................................................ 9232 II 

Meperidine Intermediate-B ................................................................................................................................................ 9233 II 

Meperidine Intermediate-C ................................................................................................................................................ 9234 II 

Dextropropoxyphene ......................................................................................................................................................... 9273 II 

Morphine ............................................................................................................................................................................ 9300 II 

Levo-alphacetylmethadol ................................................................................................................................................... 9648 II 

Alfentanil ............................................................................................................................................................................ 9737 II 

Remifentanil ....................................................................................................................................................................... 9739 II 

Sufentanil ........................................................................................................................................................................... 9740 II 

Carfentanil ......................................................................................................................................................................... 9743 II 

Tapentadol ......................................................................................................................................................................... 9780 II 

Fentanyl ............................................................................................................................................................................. 9801 II 

The company plans to bulk 

manufacture the listed controlled 

substances as analytical materials, 

proficiency test materials, and academic 

research materials for distribution to its 

customers. No other activities for these 

drug codes are authorized for this 

registration. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–04057 Filed 2–24–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–965] 

Importer of Controlled Substances 

Application: Lyndra Therapeutics 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Lyndra Therapeutics has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTAL

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 28, 2022. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 28, 2022. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 13, 2022, 

Lyndra Therapeutics, 65 Grove Street, 

Suite 301, Watertown, Massachusetts 

02472, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Methadone .................... 9250 II 

The company plans to develop the 

formulation and process, and then 

manufacture the finished oral dosage 

form for use in preclinical and human 

clinical trials and analysis. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Matthew J. Strait, 

Deputy Assistant Administrator. 

[FR Doc. 2022–04061 Filed 2–24–22; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request; Miner’s 

Claim for Benefits and Employment 

History 

ACTION: Notice of availability; request 

for comments. 

SUMMARY: The Department of Labor 

(DOL) is submitting this Office of 

Workers’ Compensation Programs 

(OWCP)-sponsored information 

collection request (ICR) to the Office of 

Management and Budget (OMB) for 

review and approval in accordance with 

the Paperwork Reduction Act of 1995 

(PRA). Public comments on the ICR are 

invited. 

DATES: The OMB will consider all 

written comments that the agency 

receives on or before March 28, 2022. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

Comments are invited on: (1) Whether 

the collection of information is 

necessary for the proper performance of 

the functions of the Department, 

including whether the information will 

have practical utility; (2) if the 

information will be processed and used 

in a timely manner; (3) the accuracy of 

the agency’s estimates of the burden and 

cost of the collection of information, 

including the validity of the 

methodology and assumptions used; (4) 

ways to enhance the quality, utility and 

clarity of the information collection; and 


lotter on DSK11XQN23PROD with NOTICES1

I I